News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,506 Results
Type
Article (87193)
Company Profile (705)
Press Release (769584)
Multimedia
Podcasts (162)
Webinars (24)
Section
Business (232956)
Career Advice (4136)
Deals (39778)
Drug Delivery (133)
Drug Development (91190)
Employer Resources (200)
FDA (18243)
Job Trends (17384)
News (397159)
Policy (39889)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (115)
Alliances (56979)
ALS (134)
Alzheimer's disease (1637)
Antibody-drug conjugate (ADC) (203)
Approvals (18228)
Artificial intelligence (446)
Autoimmune disease (43)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (483)
Bladder cancer (116)
Brain cancer (45)
Breast cancer (430)
Cancer (3463)
Cardiovascular disease (299)
Career advice (3550)
Career pathing (36)
CAR-T (225)
CDC (45)
Cell therapy (618)
Cervical cancer (29)
Clinical research (74836)
Collaboration (1254)
Company closure (4)
Compensation (844)
Complete response letters (47)
COVID-19 (2939)
CRISPR (74)
C-suite (478)
Cystic fibrosis (128)
Data (3638)
Decentralized trials (2)
Denatured (58)
Depression (92)
Diabetes (408)
Diagnostics (7034)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (211)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (178)
Earnings (98616)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132313)
Executive appointments (947)
FDA (20426)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1113)
Gene editing (160)
Generative AI (44)
Gene therapy (489)
GLP-1 (982)
Government (5339)
Grass and pollen (7)
Guidances (330)
Healthcare (20934)
HIV (48)
Huntington's disease (32)
IgA nephropathy (52)
Immunology and inflammation (207)
Immuno-oncology (17)
Indications (45)
Infectious disease (3153)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (155)
Interviews (814)
IPO (17919)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (67)
Layoffs (619)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (494)
Lymphoma (250)
Machine learning (18)
Management (65)
Manufacturing (545)
MASH (115)
Medical device (14812)
Medtech (14829)
Mergers & acquisitions (22662)
Metabolic disorders (1048)
Multiple sclerosis (114)
NASH (23)
Neurodegenerative disease (177)
Neuropsychiatric disorders (49)
Neuroscience (2506)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (528)
Opinion (302)
Ovarian cancer (111)
Pain (149)
Pancreatic cancer (142)
Parkinson's disease (212)
Partnered (27)
Patents (377)
Patient recruitment (250)
Peanut (56)
People (66009)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23071)
Phase II (32492)
Phase III (24465)
Pipeline (2403)
Policy (276)
Postmarket research (3554)
Preclinical (10419)
Press Release (72)
Prostate cancer (169)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (588)
Real estate (7409)
Recruiting (76)
Regulatory (27620)
Reports (64)
Research institute (2671)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (15)
RSV (62)
Schizophrenia (115)
Series A (183)
Series B (137)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (39)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (102)
Vaccines (998)
Venture capital (63)
Weight loss (363)
Women's health (56)
Worklife (21)
Date
Today (129)
Last 7 days (743)
Last 30 days (2544)
Last 365 days (34166)
2025 (23045)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (77)
Alaska (7)
Arizona (292)
Arkansas (14)
Asia (50763)
Australia (8914)
California (8781)
Canada (2663)
China (820)
Colorado (370)
Connecticut (389)
Delaware (237)
Europe (116562)
Florida (1300)
Georgia (302)
Hawaii (3)
Idaho (67)
Illinois (783)
India (45)
Indiana (424)
Iowa (19)
Japan (264)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1201)
Massachusetts (6636)
Michigan (294)
Minnesota (537)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (99)
New Hampshire (75)
New Jersey (2421)
New Mexico (31)
New York (2398)
North Carolina (1342)
North Dakota (10)
Northern California (3902)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1845)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3319)
Tennessee (142)
Texas (1364)
United States (32660)
Utah (263)
Virginia (237)
Washington D.C. (82)
Washington State (754)
West Virginia (4)
Wisconsin (90)
There are 857,506 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MadSci Announces $10 Million Oversubscribed Seed Financing to Advance Smart Technology for Neurologic Conditions
September 9, 2025
·
3 min read
Press Releases
Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform
September 9, 2025
·
4 min read
Press Releases
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
September 9, 2025
·
9 min read
Press Releases
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
September 9, 2025
·
5 min read
Press Releases
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
September 9, 2025
·
7 min read
Press Releases
Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes
September 9, 2025
·
2 min read
Press Releases
Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia
September 9, 2025
·
3 min read
Press Releases
Saol Therapeutics Receives Complete Response Letter from FDA for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD)
September 9, 2025
·
3 min read
Press Releases
Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration
September 9, 2025
·
3 min read
Press Releases
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres
September 9, 2025
·
2 min read
1 of 85,751
Next
